FGF21 and obesity due to melanocortin 4 receptor deficiency: In contrast, endogenous FGF21 increased energy expenditure in the setting of low protein, high-energy intake, contributing to weight loss [42, 44], and FGF21 overexpression or pharmacological administration of FGF21 had similar effects in the context of obesity or diabetes [45, 46].